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S-glutathionylationbrief exposure of HL60 cells to a mixture of 5-chloro-2-methyl-4-isothiazolin-3-
one (CMI) and 2-methyl-4-isothiazolin-3-one (MI) shifts the cells into a state of oxidative stress that induces
apoptosis and necrosis. In this study, ﬂow cytometric analysis showed that CMI/MI induces early
perturbation of calcium homeostasis, increasing cytosolic and mitochondrial calcium and depleting the
intracellular endoplasmic reticulum (ER) stores. The calcium chelator BAPTA-AM reduced necrosis and
secondary necrosis, the loss of ΔΨm and S-glutathionylation induced by necrotic doses of CMI/MI, but did not
protect against CMI/MI-induced apoptosis, mitochondrial calcium uptake and mitochondrial hyperpolariza-
tion. This indicates that increased cytoplasmic calcium does not have a causal role in the induction of
apoptosis, while cross-talk between the ER and mitochondria could be responsible for the induction of
apoptosis. GSH-OEt pretreatment, which enhances cellular GSH content, reduced S-glutathionylation and
cytosolic and mitochondrial calcium levels, thus protecting against both apoptosis and necrosis shifting to
apoptosis. Therefore, the degree of GSH depletion, paralleled by the levels of protein S-glutathionylation, may
have a causal role in increasing calcium levels. The mitochondrial calcium increase could be responsible for
apoptosis, while necrosis is associated with cytoplasmic calcium overload. These ﬁndings suggest that S-
glutathionylation of speciﬁc proteins acts as a molecular linker between calcium and redox signalling.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
The combination of 5-chloro-2-methyl-4-isothiazolin-3-one (CMI)
and 2-methyl-4-isothiazolin-3-one (MI), in an approximate ratio of
3:1, is commonly used to preserve cosmetic and body care products
[1], as it is active at very low concentrations against bacteria, fungi and
yeast. However, the molecular mechanism of this biocide is not fully
understood. We have shown that brief exposure of HL60 cells or
human keratinocytes to CMI/MI perturbs the normal redox balance,
shifts the cells into a state of oxidative stress and induces apoptosis at
low concentrations and necrosis at higher concentrations [2,3].
Glutathione (GSH) depletion, reactive oxygen species (ROS) genera-
tion, hyperpolarization of mitochondrial transmembrane potential
(ΔΨm) and formation of protein-GSH mixed disulphides (S-glutathio-
nylation) are early molecular events that precede the induction of cell
death by CMI/MI in HL60 cells. The extent and kinetics of GSH
depletion and S-glutathionylation appear to determine whether cells
undergo apoptosis or necrosis. The development of apoptosis is39 0577 234903.
l rights reserved.associated with loss of ΔΨm and caspase-9 and -3 activation [4].
Recently it was reported that the toxic effects of methylisothiazoli-
none on neurones are mediated by a caspase-independent pathway
[5].
Increased intracellular free Ca2+ may play an important role in cell
death induced by sulphydryl active agents such as CMI/MI, oxidants
and free radicals [6–9]. Some reports suggest that an increase in
intracellular free Ca2+ enhances oxidative stress, damages mitochon-
dria, activates calcium-dependent enzymes and induces cell death
[10–13]. In contrast, other authors have suggested that the disruption
of Ca2+ homeostasis is a late event associated with loss of membrane
integrity and does not necessarily have a direct role in oxidant-
induced cell death [14]. In addition to an increase in free Ca2+,
decreased levels of intracellular or extracellular Ca2+ can cause
apoptosis, as documented by DNA fragmentation [15]. It has been
reported that calcium chelators induce apoptosis in cultured cells,
concomitant with a decrease in both intracellular ionised calcium and
total cell calcium, suggesting that the loss of calcium homeostasis,
rather than a sustained rise in cytosolic calcium, is a determining
factor in cell death by apoptosis [16]. Moreover, mitochondria are
essential for cellular energy metabolism and Ca2+ homeostasis. Recent
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during episodes of cellular Ca2+ overload initiates a cascade of events
culminating in cell death [12,13,17]. Cell death may proceed via
necrotic or apoptotic mechanisms depending on the rate of consump-
tion and depletion of ATP [18]. The sequence of mitochondrial and
plasmatic alterations and the ﬂuctuations in intracellular Ca2+ and
GSH concentrations during the induction and execution of apoptosis
by ROS are not exactly known. In fact, these processesmay overlap and
the sequence of events could differ among cell types and be
modulated by the cell-death stimuli.
The aim of this study was to evaluate the participation of Ca2+ in
apoptosis or necrosis induced by CMI/MI treatment in HL60 cells (a
good cellular model used in our previous experiments) [4]. We used
intracellular calcium chelators and a redox modulator of intracellular
GSH to investigate the relationships among intracellular calcium,
changes in glutathione content, S-glutathionylation and ΔΨm, and
induction of apoptosis or necrosis in HL60 cells exposed to CMI/MI.
We report here that, in an early phase of its action, CMI/MI induces
a calcium release from ER stores followed by mitochondrial calcium
loading, which in turn triggers mitochondrial impairment and cell
death.
Our results suggest that the ER-mitochondrial calcium transfer and
cytoplasmic calcium overload, both likely orchestrated by S-glutathio-
nylation of speciﬁc proteins, play a role in CMI/MI-induced apoptosis
and necrosis, respectively.
2. Materials and methods
2.1. Reagents
A mixture of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-
methyl-4-isothiazolin-3-one, in an approximate ratio of 3:1 (CMI/
MI, commercially named Kathon CG™, was obtained from Rohm and
Haas (Spring House, PA, USA)) [3]. Foetal calf serum (FCS) was
obtained from Gibco (Milan, Italy), and HPLC-grade reagents were
purchased from Mallinckrodt Baker Inc. (Phillipsburg, NJ, USA). The
OmniSpher C18 reversed-phase HPLC column (250×4 mm) was
purchased from Varian (Lake Forest, CA, USA). Monobromobimane
(mBrB) was obtained from Calbiochem (La Jolla, CA, USA). RPMI
medium, 2′,7′-dichloroﬂuorescein diacetate (DCFH-DA), Rhodamine
123 (Rhod123), propidium iodide (PI), glutathione (GSH), glutathione
monoethyl ester (GSH-OEt), N-ethylmaleimide (NEM), dithiothreitol
(DTT) and trichloroacetic acid (TCA) were obtained from Sigma-
Aldrich Corp. (St. Louis, MO, USA). Fluorescein isothiocyanate (FITC)-
labelled AnnexinV (AnnxV) kit was obtained from Boehringer
Ingelheim Bioproducts (Vienna, Austria). 1,2-bis-(2-aminophenoxy)-
ethane-N,N,N′,N′-tetraacetic acid acetoxymethyl ester (BAPTA-AM),
ethylene glycol-bis (2-aminoethyl)-N,N,N′N′-tetracetic acid), acetox-
ymethyl ester (EGTA-AM), Rhodamine 2 acetoxymethyl ester (Rhod-
2-AM), and thapsigargin, were purchased from Molecular Probe
(Milan, Italy).
2.2. Cell treatment
HL60 cells were donated by Prof. Marcella Cintorino, Policlinico Le
Scotte, Siena. The cells were grown in RPMI medium supplemented
with 10% foetal calf serum (FCS), glutamine (2 mM), penicillin (100 IU/
ml) and streptomycin (100 µg/ml) at 37 °C in a humidiﬁed atmosphere
containing 5% CO2.
HL60 cells between the 5th and 20th passages were treated as
previously reported [2]. The cells, at the concentration of 5×105/ml,
were incubated at 37 °C in RPMImedium containing 10% FCS. After 1 h
of incubation, the cells were exposed to increasing concentrations of
CMI/MI (0.001–0.1%) (Rohm and Haas, Spring House, PA, USA) for
10min. Theywere thenwashedwith phosphate-buffered saline (PBS),
collected by centrifugation, resuspended in freshmedium at 1×106/ml(0 time) and incubated at 37 °C for 3 h. At speciﬁed times, cells were
washed and resuspended in PBS and prepared for speciﬁc assays as
reported below. Cells treated with vehicle only (PBS) served as
controls.
We chose the concentrations 0.001%, 0.01%, 0.05% and 0.1% of CMI/
MI solution as supplied by the manufacturer (respectively 0.15, 1.5, 7.5
and 15 ppm of active ingredients). In fact the maximum allowed
concentration in “rinse off” products is 0.1% of Kathon CG (sold as a
dilute aqueous solution of 1.5% of the two isothiazolinones, corre-
sponding to 15 ppm of active ingredients), while in “leave on”
products it is 0.05% (corresponding to circa 7.5 ppm).
In some experiments, cells were incubated with the intracellular
chelators 1,2-bis-(2-aminophenoxy)-ethane-N,N,N′,N′-tetraacetic
acid acetoxymethyl ester (BAPTA-AM) (2–10 µM) or ethylene glycol-
bis-(2-aminoethyl)-N,N,N′N′-tetracetic acid) acetoxymethyl ester
(EGTA-AM) (5–15 µM) (Molecular Probe, Milan, Italy) for 30 min or
with the cell permeable glutathione monoethyl ester (GSH-OEt)
(10 mM) (Sigma-Aldrich, Milan, Italy) for 3 h in RPMI medium+FCS
10% at 37 °C before incubation with the preservative.
2.3. Flow cytometric assays
All ﬂow cytometric analyses, except the intracellular and intrami-
tochondrial calcium assays, were performed on a ﬂow cytometer
(Becton Dickinson, Mountain View, CA, USA) equipped with an
excitation laser line at 488 nm and Cell Quest software (Becton
Dickinson) following staining of samples with speciﬁc ﬂuorochrome.
2.3.1. Evaluation of transmembrane potential using double staining with
Rhod123
Mitochondrial transmembrane potential was assessed by ﬂow
cytometry uptake of the cationic lipophilic dye Rhodamine 123
(Rhod123) and PI using a commercial product (Sigma-Aldrich, Milan,
Italy). The Rhod123 (green ﬂuorescence) and the PI (red ﬂuorescence)
were both collected in a log scale through a 530±20 and 575±15 nm
band pass ﬁlter, respectively.
2.3.2. Determination of necrosis
The criterion commonly used to examine necrosis is the loss of
membrane integrity, as measured by massive inﬂux of 50 µg/ml PI in
non-permeabilized cells. Brieﬂy, controls and treated cells were
suspended in PBS containing 50 µg/ml PI and the ﬂuorescence was
analysed by ﬂow cytometry. Under these conditions, necrotic cells or
late apoptotic cells exhibited high ﬂuorescence, whereas the ﬂuores-
cence was absent or low in early apoptotic cells.
2.3.3. Determination of apoptosis
DNA content was analysed using PI as previously described. To
assess apoptosis or necrosis in the same cells, we measured PS
expression using ﬂuorescein (FITC)-labelled Annexin V (AnnxV) and PI
uptake using a commercial kit (Boehringer Ingelheim Bioproducts,
Vienna, Austria) according to the manufacturer's instructions [2].
2.3.4. Measurement of intracellular and intramitochondrial calcium level
Cytoplasmic calcium changes were monitored using the ﬂuores-
cent calcium indicator Fura Red (Molecular Probe, Italy). It was loaded
into the cells as its acetoxymethyl ester form, Fura Red-AM, and
trapped in the cytoplasm following deesteriﬁcation by intracellular
esterases. This indicator is excited at 488 nm, emits ﬂuorescence with
a maximum at 660 nm, and exhibits decreased ﬂuorescence intensity
after the binding of calcium ions [19]. HL60 cells were preloaded with
Fura Red-AM to a ﬁnal concentration of 5 µM before CMI/MI
treatment. The mixture contained HL60 cells (1×106/ml, Fura Red-
loaded), EGTA 0.5 mM and PBS 1X+FCS 5%, pH 7.4. It was incubated at
37 °C in the dark for 30 min. Fura Red-AM-loaded cells were treated
with CMI/MI and analysed with FACSLSRII (Becton Dickinson) to
Fig. 1. CMI/MI induces a calcium increase in HL60 cells. HL60 cells stained with Fura
Red-AM in Ca2+-free medium. After warming Fura Red-AM-labelled cells for 1 min at
37 °C, we analysed their basal ﬂuorescence for approximately 1 min with FACSLSRII
before adding increasing doses of CMI/MI. The calcium-dependent ﬂuorescence of Fura
Red-AM was measured as the ratio FL5/FL4 (Fura Red Violet/Fura Red blue). The
ﬂuorescence was recorded for 512 s. The effect of the addition of thapsigargin is also
presented. These experiments were performed three times with very similar results.
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dependent ﬂuorescence of Fura Red-AM was measured as the ratio
F488nm/F407nm for live cells and displayed as a function of time. After
warming Fura Red-AM-labelled cells for 1 min at 37 °C, we analysed
their basal ﬂuorescence for approximately 1 min before adding
increasing doses of CMI/MI. The mean cytoplasmic ratio (R488/407) was
evaluated in the resting cells and again after permeabilization of the
membranes with the Ca2+ ionophore, ionomycin (1 µM).
To measure intramitochondrial calcium, we used the ﬂuorescent
Ca2+ indicator Rhod-2-AM (Molecular Probe, Italy). The AM-ester of
this dye does not bind Ca2+ but is readily hydrolyzed to Rhod-2 by
endogenous esterases once the dye is inside the cells. Since Rhod-2-
AM is positively charged, it was ﬁrst reduced with NaBH4 and then
loaded into 1×106 cells/ml at a concentration of 5 µM for 1 h at 37 °C.
Following extensive washing, the cells were incubated for 12–16 h in
37 °C to allow sequestration of Rhod-2 into mitochondria. Samples
were analysed with FACSLSRII (Becton Dickinson) [20].
2.4. HPLC assays of glutathione and glutathione-protein-mixed
disulphide
The measurement procedure was described by us previously [4]
and was modiﬁed from Mansoor et al. [21]. Glutathione-protein-
mixed disulphides were measured as liberated glutathione and
expressed as glutathione equivalents (nmoles/mg protein). Protein
concentration was estimated in the supernatant of lysed cells
according to the Bradford method [22].
2.4.1. Analysis of glutathione
At different times of incubation, 200 µl of cells resuspended in PBS
(containing 1×106 cells) were precipitated with 6% (w/v) TCA (ﬁnal
concentration) (Sigma-Aldrich, Milan, Italy). After centrifugation of
the sample (2 min at 10,000 ×g), the supernatant was neutralized
under saturating conditions of solid NaHCO3 and incubated with
1 mMmonobromobimane (mBrB) (ﬁnal concentration) in the dark at
room temperature for 15 min. After centrifugation (2 min at
10,000 ×g), 90 µl of the supernatant were acidiﬁed with 20 µl of 37%
HCl and injected into the HPLC column.
2.4.2. Analysis of glutathione-protein-mixed disulphide
200 µl of resuspended cells (containing 1×106 cells) were reacted
with 50 µl of 10 mM N-ethylmaleimide (NEM) (Sigma-Aldrich, Milan,
Italy) for 5 min. After deproteinization with 6% TCA (ﬁnal concentra-
tion) and centrifugation at 10,000 ×g for 2 min, the protein pellet of
NEM-treated samples was washed twice with 1 ml of 1.5% (w/v) TCA
to remove traces of NEM and low molecular weight compounds in
the sample. The pellet was then resuspended in 0.2 ml of 1 mM
K3EDTA. After saturationwith solid NaHCO3, 5 µl of 50mMDTT (Sigma-
Aldrich, Milan, Italy) were added to the resuspension and the sample
was maintained under continuous agitation at room temperature for
20min. The samplewas centrifuged at 10,000 ×g for 2min and 100 µl of
the supernatant were deproteinized with 40 µl of 60% (w/v) TCA. After
centrifugation, 100 µl of the supernatant were neutralized with solid
NaHCO3 up to saturation and reacted with 10 µl of 40 mM mBrB
(Calbiochem, La Jolla, CA, USA). After 15 min of incubation at room
temperature in the dark, the sample was acidiﬁed with HCl as above.
Samples were injected into the HPLC column. Solvent A was
0.25% (v/v) acetic acid, adjusted to pH 3.09 with 1 N NaOH, and
solvent B was methanol. The elution proﬁle was as follows: 0–8 min,
20% B; 8–15 min, 20–40% B; 15–25 min, 40–100% B. A constant ﬂow
rate of 1.0 ml/min was applied. HPLC separation was performed with
a Hewlett-Packard 1100 series apparatus, equipped with ﬂuorescence
detection (excitation, 380 nm; emission 480 nm). The retention time
for glutathione was 12.2.
Appropriate concentrations of glutathione were used to prepare
calibration curves in PBS or in PBS+DTT, respectively. The calibrationcurves were linear from 0.3 µM to 100 µM (3.2 pmoles/injection to
1073 pmoles/injection). The detection limit was 2 pmoles/injection
(injection volume 0.02 ml).
2.5. Statistics
The results are presented as means±SD from at least three
independent experiments. Student's t-test was used to assess the
signiﬁcance of differences between the treatment and control
groups.
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3.1. CMI/MI treatment increases the cytosolic calcium
To investigate the role of Ca2+ in CMI/MI-induced cytotoxicity, we
analysed the alterations of intracellular calcium levels induced by
CMI/MI with the ﬂuorescent probe Fura Red-AM by FACS. Unlike most
other Ca2+ indicators, Fura Red-AM ﬂuorescence decreases once the
indicator binds Ca2+. The ratio F488nm/F407nm, however, increases with
rising Ca2+ concentration. Fig. 1 shows that the addition of CMI/MI to
Fura Red-AM-loaded HL60 cells in the absence of extracellular Ca2+
induced a rapid and sustained increase in intracellular Ca2+. At all CMI/
MI doses, the ﬂuorescence intensity increased immediately in a dose-
dependent manner, remained sustained and did not decay during the
10 min of measurement. Fig. 1 shows that, after exposure to CMI/MI at
both apoptotic and necrotic doses, the subsequent addition of 0.1 µM
thapsigargin, an inhibitor of endoplasmic reticulum (ER) Ca2+-ATPase
that discharges intracellular Ca2+ stores [23] did not further increase
calcium levels except at the ﬁnal concentration of 0.001% and at 0.01%
(increase barely evident). A slight increase in ﬂuorescence was
observed in the presence of external calcium, suggesting that the
primary source of Ca2+ is most likely the ER, the primary site of Ca2+
storage in eukaryotic cells (data not shown).
3.2. Effects of BAPTA-AM on apoptosis and necrosis induced by CMI/MI
Next we investigated whether buffering the level of Ca2+ with cell
permeant Ca2+ chelators could inhibit CMI/MI-induced cytotoxicity
[24,25]. Before CMI/MI treatment, we pretreated HL60 cells for 30 minFig. 2. Effect of 10 µM and 2 µM BAPTA-AM on calcium increases induced by 1 µM ionomycin
incubated for 30 min with and without 10 µM and 2 µM BAPTA-AM and than stained with Fu
37 °C, we analysed their basal ﬂuorescence for approximately 1 minwith FACSLSRII before ad
measured as the ratio FL5/FL4 (Fura Red violet/Fura Red blue). The ﬂuorescence was recordwith increasing concentrations (2–10 µM) of the membrane perme-
able intracellular Ca2+ chelator BAPTA-AM, an agent that buffers
intracellular Ca2+ released from ER, to determine whether we could
buffer the increase in Ca2+ caused by CMI/MI. In this and subsequent
experiments, we used only two doses of CMI/MI: one apoptotic
(0.01%) and one necrotic (0.05%).
As shown in Fig. 2, 10 µM BAPTA-AM completely blocked the
increase in Ca2+ induced by 0.01% and 0.05% CMI/MI, as well as the
increase induced by 1 µM ionomycin and thapsigargin. Figs. 3a and b
show the percentage of apoptotic and necrotic cells, respectively, after
CMI/MI with and without BAPTA-AM.
The apoptotic cells obtained by treatment with 0.01% CMI/MI
exhibited not only subdiploid DNA content but also propidium iodide
(PI) uptake (Figs. 3a, b), conﬁrming that secondary necrosis is
apoptosis-derived as previously reported in our studies [2–4].
Unexpectedly we found that 10 µM BAPTA-AM was cytotoxic for
HL60 cells: 55.23% of cells pretreated with BAPTA-AM showed
subdiploid DNA content after 3 h (Fig. 3a) and only 9.51% showed PI
uptake (Fig. 3b). The proportion of apoptotic cells induced by BAPTA-
AM decreased from 55.23% to 28.24% and 4.16%, respectively, when
exposed to 0.01% and 0.05% CMI/MI. It is evident that the preservative
had a protective effect against the apoptosis induced by BAPTA-AM,
suggesting that it is CMI/MI that prevents BAPTA-AM-induced
apoptosis and not the contrary. Conversely the PI uptake in cells
exposed to CMI/MI was greatly decreased by BAPTA-AM; thus it is
clear that BAPTA-AM protected against secondary necrosis-derived
apoptosis and against necrosis. Nevertheless, as BAPTA-AM itself
induced apoptosis and it is difﬁcult to ascertain its effect on CMI/MI-
induced apoptosis, we evaluated if smaller concentrations of BAPTA-, 0.1 µM thapsigargin and 0.01% and 0.05% CMI/MI in Ca2+-free medium. HL60 cells were
ra Red-AM in Ca2+-free medium. After warming Fura Red-AM-labelled cells for 1 min at
ding 0.01% and 0.05% CMI/MI. The calcium-dependent ﬂuorescence of Fura Red-AMwas
ed for 512 s. These experiments were performed three times with very similar results.
Fig. 3. Effects of 10 µM and 2 µM BAPTA-AM on apoptosis and necrosis induced by CMI/MI in HL60 cells. Cells were incubated for 30minwith andwithout 10 µM and 2 µM BAPTA-AM
and treated with CMI/MI (0.01%, 0.05%) for 10 min, resuspended in fresh medium and incubated at 37 °C for 3 h. (a) Histograms±SD of cells showing subdiploid DNA content (Sub-
G1), (b) histograms±SD of cells showing PI uptake (average of ﬁve separate experiments). (c) dot-plot of biparametric analysis of HL60 cells stained with AnnxV-FITC (FL1) and PI
(FL3). The lower left quadrant (AnnxV−/PI−) represents viable cells, whereas the upper left (AnnxV+/PI−) and upper right (AnnxV+/PI+) quadrants show apoptotic and necrotic or late
apoptotic cells, respectively, and the lower right quadrant represents damaged cells (AnnxV−/PI+). The X-axis shows log FL3-ﬂuorescence intensity; the Y-axis indicates the log FL1-
ﬂuorescence intensity. Similar data were obtained in ﬁve independent experiments. ⁎Pb0.05 and ⁎⁎⁎Pb0.001 statistically signiﬁcant with respect to cells treated with CMI/MI
without BAPTA-AM (Student's t test).
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tion of BAPTA-AM that can be used without apoptotic effects is 2 µM;
this ﬁnal concentration is able to inhibit the increase of calcium
induced by both 0.01% and 0.05% CMI/MI (Fig. 2). Therefore, we used
this ﬁnal concentration for the subsequent experiments. In these
critical experiments, we examined both the appearance of subdiploid
DNA content and phosphatidylserine (PS) exposure by AnnxV-FITC
binding, an early index of apoptosis. Fig. 3c indicates that the presence
of 2 µM BAPTA-AM did not induce apoptosis in HL60 cells and offered
no protection against early CMI/MI-induced apoptosis (indeed there
was an increase of AnnxV-positive cells from 3.96% to 9.59%), although
there was strong protection against late apoptosis (AnnxV+/PI+ cells
from 52.67 to 37.7%). 2 µM BAPTA-AM also protected against necrosis
induced by 0.05% CMI/MI (AnnxV+/PI+ cells from 89.56 to 40.36%)
while AnnxV-positive cells increased signiﬁcantly from 0.8% to 3.42%.
These results were conﬁrmed by an increased percentage of cells withsubdiploid DNA content (Fig. 3a) and a decreased percentage of cells
with PI uptake (Fig. 3b).
EGTA-AM, which can also combinewith intracellular calcium, gave
results similar to those obtained with BAPTA-AM (data not shown).
3.3. Effect of BAPTA-AM on changes in ΔΨm and mitochondrial calcium
uptake
We then evaluated if 2 µM BAPTA-AM protected against changes
in ΔΨm induced by CMI/MI. As reported in Fig. 4a, the percentage of
hyperpolarized cells observed as early as 0 time after CMI/MI
exposure did not decrease in cells treated with BAPTA-AM and
CMI/MI at both necrotic and apoptotic doses. Instead, there was
evident protection against depolarization induced by 0.05% CMI/MI:
the proportion of depolarized cells at 3 h after 0.05% CMI/MI
decreased from 97.38% to 30.22% in the presence of BAPTA-AM. In
Table 1
Mean Rhod 2-AM ﬂuorescence intensity
– +2µM Bapta +10mM GSH-OEt
CTR 1528.5±84.9 1640.5±156.3 1484.5±180.7
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induced by 0.01% CMI/MI.
To evaluate if the rapid increase in cytosolic calcium induced by
CMI/MI was followed by mitochondrial calcium loading, we evaluated0.01% CMI/MI 2140.0±144.9 2186.5±126.6 1732.3±123.2⁎
0.05% CMI/MI 2915.5±240.2 3042.5±103.9 2062.0±205.5⁎
Values as expressed as mean±SD of Mean Rhod 2-AM ﬂuorescence intensity; (n=3).
⁎ Pb0.05 statistically signiﬁcant with respect to cells treated with CMI/MI without
BAPTA-AM and GSH-OEt (Student's t test).mitochondrial free calcium using Rhod-2-AM after reduction with
NaBH4.
The ability of Rhod-2-AM to detect changes in mitochondrial
calcium and not cytoplasmic calciumwas veriﬁed after stimulation of
HL60 cells with thapsigargin. As shown in Fig. 4b, Rhod-2-AM loading
in control cells did not increase ﬂuorescence after the addition of
0.1 µM thapsigargin (as instead was recorded after loading with
cytoplasmic Fura Red-AM), indicating that Rhod-2-AM is not localized
in cytoplasm; conversely it increased after addition of 0.01% or 0.05%
CMI/MI. The Rhod-2-AM ﬂuorescence gradually increased starting
about 10 min after CMI/MI addition (data not shown). Table 1 shows
that the mean Rhod-2-AM ﬂuorescence intensity increased in a dose-
dependent manner after CMI/MI exposure and that it was not affected
by 2 µM BAPTA-AM.
3.4. Effects of BAPTA-AM on GSH depletion and S-glutathionylation
To determine whether the calcium increase was causally linked to
GSH depletion and S-glutathionylation, we evaluated the GSH, GSSG
and GSSP contents in cells preincubated with 2 µM BAPTA-AM. As
illustrated in Fig. 5, 2 µM BAPTA-AM signiﬁcantly attenuated the
depletion of GSH (Fig. 5a) and S-glutathionylation (Fig. 5b) induced by
0.05% CMI/MI at 0 time as well as at 3 h after treatment; no BAPTA-
AM-induced changes in GSH or S-glutathionylation levels were
observed after treatment with the apoptotic dose of CMI/MI. There
was no signiﬁcant oxidized glutathione (GSSG) change in cells
exposed to CMI/MI, with or without BAPTA-AM, with respect to
controls (data not shown).
3.5. Effects of GSH-OEt on S-glutathionylation and apoptosis or necrosis
induced by CMI/MI
To investigate the effect of GSH levels on CMI/MI cytotoxicity, we
pre-treated cells with GSH-OEt (Fig. 5). The addition of 10 mM GSH-
OEt to the culture medium for 3 h followed by replacement of the
medium before CMI/MI exposure increased the GSH content without
affecting S-glutathionylation. The increase in GSH signiﬁcantly
protected against CMI/MI-induced GSH depletion (Fig. 5a) and
formation GSSP at 0 time (Fig. 5b) as well as at 3 h after CMI/MIFig. 4. Effects of 2 µM BAPTA-AM on ΔΨm changes and on mitochondrial calcium
increases after treatment with CMI/MI in HL60. (a) Cells were incubated for 30minwith
and without 2 µM BAPTA-AM and treated with CMI/MI (0.01%, 0.05%) for 10 min,
resuspended in fresh medium and incubated at 37 °C. At the indicated times, untreated
and CMI/MI-treated HL60 cells were loaded for 30 min with Rhod123 (1 µg/ml ﬁnal
concentration) and the ﬂuorescence intensity was determined by ﬂow cytometry. Filled
histograms=control cells; open histograms=CMI/MI-treated cells. The Y-axis shows the
cell number; the X-axis indicates the Rhodamine123 ﬂuorescence intensity in log FL1.
(b) HL60 cells stained with Rhod-2-AM at a concentration of 5 µM for 1 h at 37 °C.
Following extensive washing, the cells were incubated for 12–16 h at 37 °C to allow
sequestration of Rhod-2-AM into mitochondria. Their basal ﬂuorescence was analysed
for approximately 1 min with FACSLSRII before the addition of 0.01% and 0.05% CMI/MI.
The Y-axis shows the cell number; the X-axis indicates the Rhod-2-AM ﬂuorescence
intensity in log FL1. The ﬂuorescence was recorded for 20 min. These experiments were
performed three times with very similar results. Solid line=control cells; dotted
line=control cells plus tapsigargin; long dashed gray line=0.01% CMI/MI-treated cells;
dashed gray line=0.05% CMI/MI-treated cells.
Fig. 5. Effects of 2 µM BAPTA-AM and GSH-OEt on GSH depletion and S-glutathionylation induced by CMI/MI in HL60 cells. Cells were incubated for 30 min with and without 2 µM
BAPTA-AM or for 3 h with and without 10 mM GSH-OEt and treated with CMI/MI (0.01%, 0.05%) for 10 min, resuspended in fresh medium and incubated at 37 °C. At the indicated
times, (a) GSH and (b) GSSP were determined by HPLC after mBrB derivatization (see Materials and methods). The values are expressed as mean±SD nmoles mg−1 proteins (n=6).
⁎⁎⁎Pb0.001; ⁎⁎Pb0.01; ⁎Pb0.05 statistically signiﬁcant with respect to cells treated with CMI/MI without BAPTA-AM and GSH-OEt (Student's t test).
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MI) (Fig. 5b). Concomitantly the percentage of apoptotic (Fig. 6a) and
necrotic cells (Figs. 6b, c) decreased and a shift from necrosis to
apoptosis occurred: the proportion of apoptotic cells recorded after
0.05% CMI/MI at 3 h increased from 7.77 to 23.60%. Conversely, if cells
pre-treated with GSH-OEt for 3 h were not washed and not
resuspended in fresh medium before CMI/MI treatment (co-treat-
ment), the induction of apoptosis or necrosis by CMI/MI was
completely blocked (Figs. 6a–c).
3.6. Effects of GSH-OEt on the CMI/MI-induced cytosolic and
mitochondrial calcium increase and on changes in ΔΨm
Cells loadedwith 10mMGSH-OEt had a higher baseline number of
cells ﬂuxing calcium (Fig. 7b) if compared with control cells (Fig. 7a).
Pre-treatment with GSH-OEt inhibited (Fig. 7b), but did not abolish,
the CMI/MI-induced increase of cytoplasmic calcium (Fig. 7a). The
addition of thapsigargin induced a further calcium increase, indicating
that CMI/MI in cells loaded with GSH-OEt did not completely deplete
the calcium stores in ER. GSH-OEt pre-treatment reduced the increaseof mitochondrial calcium induced by both doses of CMI/MI (Fig. 7c and
Table 1).
Additional experiments were performed to examine if GSH-OEt
pre-treatment protected against the CMI/MI-induced changes in ΔΨm.
The hyperpolarization induced by CMI/MI at both apoptotic and
necrotic doses at 0 time (Figs. 8a–c) and the depolarization at 3 h were
signiﬁcantly reduced by GSH-OEt pre-treatment (Figs. 8b–d).
4. Discussion
In this study, we have shown that early alteration of Ca2+
homeostasis is involved in the molecular mechanism of CMI/MI. The
addition of CMI/MI to Fura Red-AM-loaded HL60 cells in the absence
of extracellular Ca2+ induced a rapid and sustained increase in
intracellular Ca2+ in a dose-dependent manner. Experiments evaluat-
ing the relative contribution of extracellular Ca2+ inﬂow and the
release of stored Ca2+ have shown that the primary source of calcium
is most likely intracellular stores. CMI/MI (except at 0.001%) blocks the
reﬁlling of Ca2+ and irreversibly depletes the Ca2+ stores in ER. In our
model, thapsigargin treatment resulted in a further increase in
Fig. 6. Effect of pre- or co-treatment with 10mMGSH-OEt on apoptosis and necrosis in HL60 cells at 3 h after CMI/MI treatment. (a, b) DNA histograms (linear scale) of HL60 cells after
70% ethanol ﬁxation, RNAse treatment and PI staining (sub-diploid DNA peak). (c) PI incorporation: ﬁlled histograms=control cells; open histograms=CMI/MI-treated cells. These
experiments were performed three times with very similar results.
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treated cells in which thapsigargin did not cause a further increase of
Ca2+ levels, indicating that the ER had already released its Ca2+.
We than investigated whether buffering the CMI/MI-induced
calcium increase could inhibit CMI/MI-induced cytotoxicity. First, we
used a potent intracellular calcium chelator BAPTA-AM, which has
been reported to inhibit apoptosis induced by calcium increases [25].
Although preincubation with 10 µM BAPTA-AM completely buffered
the increase of Ca2+ induced by both doses of CMI/MI, apoptosis was
not inhibited while necrosis was effectively reduced by switching
from necrosis to apoptosis. In contrast to literature reports [24,25], we
found that brief incubationwith 10 µM BAPTA-AM induced apoptosis,as documented by subdiploid DNA content. It has been reported that
BAPTA-AM can induce apoptosis in HL60 cells, but only after
prolonged incubation (4 h and 24 h) and at ﬁnal concentrations
ranging from 10 to 20 µM [15]. Interestingly, cultures pretreated with
10 µM BAPTA-AM had a decreased percentage of apoptotic cells when
treated with CMI/MI, showing not only that BAPTA-AM does not
protect against apoptosis but that it is CMI/MI that protects against
apoptosis induced by BAPTA-AM. However, this result is an indirect
evidence that CMI/MI affects calcium homeostasis; a plausible
explanation is that the addition of CMI/MI to HL60 pretreated with
BAPTA-AM prevented the Ca2+ decrease and the subsequent signalling
cascade of apoptosis otherwise induced by BAPTA-AM, likely releasing
Fig. 7. Effect of 10mMGSH-OEt on cytoplasmic andmitochondrial calcium increases induced by 0.01% and 0.05% CMI/MI in Ca2+-freemedium. (a, b) HL60 cells stainedwith Fura Red-
AM were exposed to CMI/MI in Ca2+-free medium and analysed with FACSLSRII. The calcium-dependent ﬂuorescence of Fura Red-AM was measured as the ratio FL5/FL4 (Fura Red
violet/Fura Red blue). The ﬂuorescence was recorded for 512 s. These experiments were performed three times with very similar results. (c) HL60 cells stained with Rhod-2-AM at a
concentration of 5 µM for 1 h at 37 °C. Following extensive washing, the cells were incubated for 12–16 h at 37 °C to allow sequestration of Rhod-2-AM into mitochondria. Their basal
ﬂuorescencewas analysed for approximately 1 minwith FACSLSRII before the addition of 0.01% and 0.05% CMI/MI. The Y-axis shows the cell number; the X-axis indicates the Rhod-2-
AM ﬂuorescence intensity in log FL1. These experiments were performed three times with very similar results. The ﬂuorescence was recorded for 20 min. Solid line=control cells;
long dashed gray line=0.01% CMI/MI-treated cells; dashed gray line=0.05% CMI/MI-treated cells.
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(2 µM) or EGTA-AM (5 µM), another intracellular calcium chelator,
conﬁrmed that chelation of Ca2+ effectively reduced necrotic cell death
and secondary necrosis shifting from necrosis to apoptosis without
suppressing the induction of apoptosis. As the increase in cytoplasmic
Ca2+ associated with apoptosis was controlled by 2 µM BAPTA-AM, it is
likely that the increase of cytoplasmic calcium does not have a causal
role in the induction of apoptosis, whereas the depletion of calcium
stores in ER could be responsible for the induction of apoptosis, as
occurs with the addition of thapsigargin in HL60 cells [15,26].
We then evaluated if 2 µM BAPTA-AM can protect against the loss
of ΔΨm, which we previously reported as a late event after CMI/MI
treatment and likely a key step in the CMI/MI-induced apoptotic and
necrotic cell death pathways [4]. The reduction of necrotic cell death
by BAPTA-AM was associated with a reduced loss of ΔΨm. The
sustained Ca2+ release from the ER can trigger Ca2+ uptake by the
mitochondria, which leads to loss of ΔΨm, mitochondrial swelling and
apoptosis [17,27–30].
Using Rhod-2-AM, we showed that CMI/MI induced an increase in
mitochondrial Ca2+, which was not inhibited by BAPTA-AM. Mito-
chondrial calcium overload is also an early event in cell death induced
by tert-butylhydroperoxide in rat hepatocytes; unlike in our study,
however, calcium chelation prevented the increase of mitochondrial
calcium and cell death [12].
Mitochondrial Ca2+ uptake has long been known to stimulate the
turnover of matrix dehydrogenases coupled to the tricarboxylic acid
cycle. This activity provides substrates for mitochondrial respiration,
which can promote an increase in ΔΨm [31]. The sustained increase inCa2+ followed by mitochondrial Ca2+ uptake and the subsequent
stimulation of respiration could explain why CMI/MI causes mito-
chondrial hyperpolarization, which we reported as an early event
associated with CMI/MI-induced apoptosis [4]. Since 2 µM BAPTA-AM
did not protect against hyperpolarization or against the intramito-
chondrial calcium increase, it seems likely that ER-mitocondrial
transfer calcium occurred. It has been reported that mitochondrial
calcium uptake is facilitated by the strategical proximity of mitochon-
dria to ER Ca2-release sites [32]. Therefore, although 2 µM BAPTA-AM
pretreatment did not inhibit mitochondrial calcium uptake (at least in
the ﬁrst 20 min after CMI/MI) or mitochondrial hyperpolarization, it
contributed to preservation of mitochondrial integrity in time, as
documented by the reduced loss of ΔΨm at 3 h after the necrotic CMI/
MI dose.
We recently reported that lower levels of S-glutathionylation are
associatedwith apoptosis and higher levels with necrosis in HL60 cells
exposed to CMI/MI [4]. The importance of S-glutathionylation during
apoptosis is conﬁrmed by other recent publications [33,34]. The
reversible S-glutathionylation, represents a post-translation oxidative
modiﬁcation that potentially regulates protein function analogous to
phosphorylation [35,36]. There is a growingnumber of proteins known
to be regulated by S-glutathionylation, including DNA binding factors
such as nuclear factor-kappaB, p53 and activator protein-1, metabolic
enzymes, mitochondrial enzymes, metallothioneines, phosphatases,
haemoglobin, caspase-3 and ion channels and pumps, such as sarco/
endoplasmic reticulum calcium ATPase (SERCA) [33,37–39].
We investigated if BAPTA-AM, which we showed to protect against
necrosis, can also affect CMI/MI-induced S-glutathionylation. Indeed,
Fig. 8. Effect of pre-treatment with 10mMGSH-OEt onΔΨm changes after CMI/MI treatment at 0 h and 3 h. Cells were incubated for 3 hwith andwithout 10mMGSH-OEt and treated
with CMI/MI (0.01%, 0.05%) for 10 min, resuspended in fresh medium and incubated at 37 °C. At the indicated times, untreated and CMI/MI-treated HL60 cells were loaded for 30 min
with Rhod123 and the ﬂuorescence intensity was determined by ﬂow cytometry. (a, b) Filled histograms=control cells; open histograms=CMI/MI-treated cells. The Y-axis shows the
cell number; the X-axis indicates the Rhodamine123 ﬂuorescence intensity in log FL1. These experiments were performed three times with very similar results. (c) Histograms±SD of
cells with increased and (d) decreased ΔΨm. ⁎ statistically signiﬁcant with respect to control Pb0.01 (Student's t test). # statistically signiﬁcant with respect to respective CMI/MI
dose Pb0.01 (Student's t test).
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glutathionylation and GSH depletion induced by 0.05% CMI/MI and
increased the output of apoptosis markers, reducing necrosis. This
conﬁrms that lower levels of S-glutathionylation are required to
activate the apoptotic machinery [4,33].
The relationship between calcium and S-glutathionylation was
investigated using a redox modulator of intracellular GSH, namely
GSH-OEt, an esteriﬁed form of glutathione able to cross the cell
membrane against the concentration gradient [40]. GSH-OEt has been
found to increase both the mitochondrial and cytoplasmic pools of
glutathione [41]. GSH-OEt pretreatment reduced S-glutathionylation
and cytosolic and mitochondrial calcium levels, thus protecting
against both apoptosis and necrosis shifting to apoptosis. These
results suggest that the increased level of GSH induced by GSH-OEt
protects against modiﬁcations of sensitive protein SH groups which
are prone to generate GSSP via CMI/MI. HL60 cells protected by GSH-
OEt become apoptotic at the high dose of CMI/MI that usually causes
necrosis and the higher GSH levels provided by GSH-OEt mayaccelerate the deglutathionylation programme. In this regard, we
previously reported that cells pre-treated with L-buthionine-[S,R]-
sulphoximine, which reduced the intracellular glutathione concentra-
tions, were more sensitive to CMI/MI, and cell death only exhibited
features of necrosis [4]. The protective effect of GSH-OEt on all
parameters was total when it was present in the culture medium
before CMI/MI (co-treatment), suggesting that the extracellular GSH-
OEt (not taken up by cells) may react with CMI/MI in the culture
medium to form a conjugate, resulting in inactivation of these
compounds. This is in line with a previous study [3] showing that,
in normal human keratinocytes, the presence of NAC in the media
before treatment with CMI/MI completely prevented the appearance
of apoptotic markers.
Nevertheless, we cannot rule out the possibility that extracellular
GSH-OEt prevents the reaction of extracellular CMI/MI with some
plasma membrane receptor rich in SH groups, probably coupled to
inositol 3-P transduction. This hypothesis could also explain why
BAPTA-AM did not prevent the increase of mitochondrial calcium,
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Ca2+ transfer between the inositol 3-P receptor and the adjacent
mitochondrial Ca2+ uptake occurred even in the presence of 1–5 µM
BAPTA-AM [26].
Our results are consistent with the study showing the cytotoxic
effect of gliotoxin, a toxic fungal epipolythiodioxopiperazine metabo-
lite which, like CMI/MI, displays a diverse range of biological activities,
including antibacterial and antiviral properties [42]. Gliotoxin induced
both apoptotic and necrotic cell death, targeted proteins with
accessible SH groups, and induced S-glutathionylation and cytosolic
calcium increases, deriving from an inﬂux through redox active
plasma membrane channels, probably by a mechanism of oxidation of
cell surface thiol groups. In agreement with our results, the inhibition
of a cytoplasmic calcium increase protected against necrosis but not
against apoptosis [42].
Moreover, it has been reported that isothiazolinone cytotoxicity [5]
in cultured neurons may be mediated by the release of Zn ions from
intracellular pools and that Fura Red binds zinc ions much more
effectively than calcium ions [43]. Hence, a more complex scenario in
which not only the disturbance of calcium homeostasis but also that of
zinc may be evoked. Many studies [44–46] have reported the ability of
increased zinc levels in the cytosol of various cell lines to induce
apoptosis or even necrosis, and there is a more recent indication [39]
that S-glutathionylation of metallothioneines (MTs), a family of
proteins rich in SH groups with high afﬁnity for zinc ions, may lead
to the release of zinc ions. Thus, it is tempting to speculate that CMI/MI
may induce S-glutathionylation of SH groups of MT, releasing zinc into
the cytosol of HL60 cells, and that complex crosstalk events between
Ca2+ and zinc may be involved in the cytotoxicity of CMI/MI.
In conclusion, our results suggest that different intracellular
calcium pools may be involved in CMI/MI cytotoxicity: cytoplasmic
calcium overload is determinant for necrosis, while the ER-mitochon-
drial calcium transfer could be responsible for the induction of
apoptosis. Moreover, we show, for the ﬁrst time, that GSH levels,
together with S-glutathionylation levels, modulate cytoplasmic and
mitochondrial calcium increases.
Hencewe propose that the commitment to apoptosis or necrosis in
HL60 cells is started by the linkage of CMI/MI to GSH or sensitive
protein SH groups, leading to the formation of thiol mixed disulphides
(thiol-CMI/MI) which in turn generates GSSP by thiol/disulphide
exchange reactions. It is likely that critical cysteine in redox active
calcium channels in the ER or plasma membrane may be a potential
target for CMI/MI. The identity of proteins that are glutathionylated is
a topic for future research. Therefore, S-glutathionylation of speciﬁc
proteins could serve as a checkpoint for the calcium signal either in
apoptosis or necrosis.
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